TL;DR
Cryopreservation, a standard step for storing immune cells, significantly impairs the ability of natural killer (NK) cells to migrate and kill tumor cells in a 3D environment. This reduced 3D function, primarily due to a sixfold drop in motility, likely explains why NK cell therapies have struggled to be effective against solid tumors, suggesting that current standard assays don't fully capture NK cell performance in vivo.
What Problem Does This Paper Address?
Adoptive transfer of natural killer (NK) cells holds promise for cancer immunotherapy, particularly against solid tumors. However, clinical trials have largely been unsuccessful. A critical bottleneck is the need to cryopreserve NK cells for safety testing and logistical reasons before clinical use. While standard in vitro assays (like degranulation and chromium release) suggest cryopreserved NK cells retain their killing ability, this doesn't translate to in vivo efficacy. The authors hypothesize that these standard assays, which typically involve direct cell-to-cell contact in 2D, fail to replicate the complex 3D microenvironment of solid tumors where NK cells must actively migrate to reach and eliminate cancer cells. This gap between in vitro performance and in vivo failure is the central problem addressed.
Methods
The researchers employed a multi-pronged approach to assess NK cell function after cryopreservation, focusing on their behavior in a 3D environment:
- Standard Cytotoxicity Assays: They used CD107a degranulation assays (measuring granule release upon target cell contact) and chromium-release assays (measuring direct tumor cell lysis) to compare fresh and cryopreserved NK cells.
- 3D Collagen Gel Model: This is the core of their methodology. They embedded NK cells and K562 tumor target cells within a 3D collagen gel, mimicking the extracellular matrix of connective tissue.
- Time-Lapse Microscopy and Tracking: Using advanced microscopy, they performed z-scans and tracked individual NK cell movements within the 3D gel over extended periods. This allowed them to quantify motility (speed, persistence) and identify cell-cell interactions.
- Automated Image Analysis: To handle the vast amount of imaging data, they developed and utilized convolutional neural networks (U-Net architecture) for automated detection and tracking of NK cells and K562 cells, as well as identification of killing events.
- 3D Cytotoxicity Assay: They combined the 3D model with time-lapse imaging to directly observe and quantify K562 cell death mediated by NK cells within the collagen gel.
Datasets
The study utilized NK cells expanded from peripheral blood mononuclear cells (PBMCs) of 11 healthy donors. They also used the K562 leukemia cell line as a target for NK cell cytotoxicity assays. No new benchmark datasets were introduced; rather, the study focused on evaluating NK cell function in a novel 3D experimental setup.
Key Insights and Ideas
- The 3D Environment is Crucial: The most significant insight is that standard 2D assays are insufficient to predict NK cell efficacy in solid tumors. The 3D collagen gel model revealed functional deficits not apparent in simpler assays.
- Motility is the Bottleneck: Cryopreservation dramatically reduces NK cell motility in 3D environments. This impaired ability to move and infiltrate is the primary driver of reduced killing efficiency in 3D, rather than a loss of intrinsic killing machinery.
- Motile NK Cells Retain Function: Importantly, the small fraction of NK cells that do remain motile after cryopreservation still exhibit normal migration speed and persistence, and retain their cytotoxic killing efficiency. This suggests the problem is one of quantity (fewer motile cells) rather than quality of the remaining motile cells.
- Cryopreservation's Impact on Motility is General: The negative effect of cryopreservation on 3D migration was observed not only in expanded primary NK cells but also in the NK92 cell line and in a different 3D matrix (carbomer hydrogel), indicating a broad impact of the cryopreservation process on NK cell motility.
- Clinical Implications for Solid Tumors: The findings provide a strong mechanistic explanation for why NK cell therapies have historically underperformed against solid tumors, highlighting the need for strategies that overcome this 3D migration deficit.
Key Results
- Cytotoxicity in 3D: Cryopreserved NK cells killed tumor cells embedded in a 3D collagen gel at a 5.6-fold lower rate compared to fresh NK cells.
- Motility Impairment: Cryopreservation led to a sixfold decrease in the fraction of motile NK cells in 3D collagen gels (from 29.2% in fresh cells to 4.9% in cryopreserved cells).
- Motility Recovery: Even after 48 hours, the motile fraction of cryopreserved NK cells did not fully recover, remaining approximately threefold lower than fresh cells.
- Motile Cell Function: Motile NK cells that remained after cryopreservation showed no significant difference in speed or directional persistence compared to fresh motile NK cells. Their intrinsic killing efficiency in 3D was only reduced by 26% (not statistically significant), much less than the overall composite killing efficiency.
- Standard Assays vs. 3D: While cryopreserved NK cells showed no significant difference in degranulation (CD107a expression), their chromium-release cytotoxicity was significantly reduced, especially at lower NK-to-target cell ratios. This aligns with the idea that reduced motility limits their ability to reach targets in a more dispersed setting.
Limitations and Future Work
- Limitations:
- The study used K562 cells, a leukemia cell line, as a model target. While useful, this may not fully represent the complexity of solid tumor microenvironments.
- The 3D collagen gel is a simplified model and doesn't encompass all aspects of the tumor microenvironment (e.g., immune suppressive factors, different extracellular matrix compositions).
- The automated detection of motile cells relied on a minimum movement threshold (≥13 µm within 5 min), which is a definition of motility.
- The study acknowledges that the killing rate calculation in 3D is an approximation due to cells moving in and out of the field of view.
- Future Work:
- The authors suggest that future NK cell therapy strategies should focus on overcoming the 3D migration deficit.
- They propose that time-lapse imaging in 3D environments could serve as a better predictor of NK cell function for patient administration than current standard assays.
- The development of NK cell expansion methods that bypass cryopreservation altogether is suggested as a potential solution.
- Further research could explore how to enhance NK cell motility in vivo or how to engineer NK cells with improved 3D infiltration capabilities.
Summary updated